A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials

BACKGROUND: The incidence and clinical significance of electrolyte abnormalities (EAs) in phase I clinical trials are unknown. The objective of this study is to evaluate the incidence and severity of EAs, graded according to CTCAE, v4.03, to identify variables associated with EAs and their prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingles Garces, Alvaro H., Ang, Joo Ern, Ameratunga, Malaka, Chénard-Poirier, Maxime, Dolling, David, Diamantis, Nikolaos, Seeramreddi, Satyanarayana, Sundar, Raghav, de Bono, Johann, Lopez, Juanita, Banerji, Udai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259582/
https://www.ncbi.nlm.nih.gov/pubmed/30316017
http://dx.doi.org/10.1016/j.ejca.2018.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259582/
https://www.ncbi.nlm.nih.gov/pubmed/30316017
http://dx.doi.org/10.1016/j.ejca.2018.08.019

Ejemplares similares